AIDS CLINICAL TRIAL GROUP A5079

艾滋病临床试验组 A5079

• 批准号: 7375893
• 负责人: JENNIFER BALFOUR
• 金额: $ 0.25万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375893
• 关键词: AIDS; CLINICAL; TRIAL; GROUP; A5079

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study will test the hypothesis that the change in viseral fat (in a cross-sectional area) will be greater with testosterone replacement than with placebo in HIV-positive men who are noted to have abdominal obesity and who have mildly to moderately reduced serum testosterone levels. The GCRC will be asked to perform DEXA scans on subjects who agree to participate in this trial.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子弹和调查员（PI）可能已经从其他NIH来源获得了主要资金，因此可以在其他清晰的条目中代表。列出的机构适用于该中心，这不一定是调查员的机构。这项研究将检验以下假设：替代睾丸激素的变化（在横截面区域）比在HIV阳性男性中的安慰剂更大，而安慰剂的变化将被认为具有腹部肥胖症，并且有轻度至中度降低血清睾丸激素水平。将要求GCRC对同意参加此试验的受试者进行DEXA扫描。